Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 3-month Randomized Double Blind Placebo-controlled Multicenter Study to Assess the Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome

NCT03692806 is registered in ClinicalTrials.gov with LNC THERAPEUTICS as lead sponsor.

NCT NCT03692806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03692806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 3-month Randomized Double Blind Placebo-controlled Multicenter Study to Assess the Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome
Lead sponsor
LNC THERAPEUTICS
Phase
Not applicable
Overall status
Completed
Start date
September 11, 2018
Completion date
December 16, 2020
Enrollment
240 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome